Unresectable Hilar Cholangiocarcinoma: Multimodality Treatment with Percutaneous and Intraluminal Plus External Radiotherapy
Authors:
- 1 November 2004
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 16 (sup5) , 55-57
Abstract
Summary The efficacy of multimodality treatment for unresectable hilar cholangiocarcinoma was evaluated in terms of outcome, survival and quality of life. Eleven patients were enrolled in the following protocol: percutaneous drainage of both right and left biliary systems; Iridium-192 intraluminal brachytherapy; replacement of the drainages with endoprotheses; external radiotherapy. Six patients completed the protocol and 5 were treated with brachytherapy alone. Mean survival was 10.5 months, similar to surgical results and higher than the control group treated with percutaneous stenting (2.75 months) or biliary drainage alone (1.75 months), with an average hospital stay of 10–15 days and no procedure-related mortality.Keywords
This publication has 8 references indexed in Scilit:
- Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinomaAnnals of Oncology, 1999
- Interventional Radiology and Radiotherapy for Inoperable Cholangiocarcinoma of the Extrahepatic Bile DuctsTumori Journal, 1998
- The role of radiotherapy in the management of extrahepatic bile duct cancer: An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- INTRALUMINAL BRACHYTHERAPY IN BILE DUCT CARCINOMASAnz Journal of Surgery, 1996
- Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapyBritish Journal of Surgery, 1995
- Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinomaClinical Radiology, 1985
- Carcinoma of the Biliary TractNew England Journal of Medicine, 1979
- Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatisThe American Journal of Medicine, 1965